1α,25-Dihydroxyvitamin D3 counteracts the effects of cigarette smoke in airway epithelial cells

In conclusion, the present study provides compelling evidences that the 1,25D3 may be considered a possible valid therapeutic option in controlling the cigarette smoke-induced epithelial barrier disruption.